Metagenomi revenue was $55.08M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $11.5M, down 42.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MGX annual revenue was $44.8M, with 160.2% growth year-over-year.
MGX past revenue growth
How has MGX's revenue growth performed historically?
Metagenomi (NASDAQ: MGX) reported Q3 2024 revenue of $11.51 million up 6.87% year over year. In the same quarter last year, Metagenomi's revenue was $12.36 million.
What was Metagenomi's revenue in 2023?
Metagenomi's annual revenue for the twelve months ending Dec 31, 2023 was $44.76 million, a 160.21% increase year over year.
How much does Metagenomi make in a day?
Based on Metagenomi annual revenue for the past two years, MGX makes an average of $84,871.23 per day.
What was Metagenomi's annual revenue growth in the past year?
As of Q1 2025, Metagenomi's revenue has grown 45.13% year over year. This is 1,081.19 percentage points lower than the US Biotechnology industry revenue growth rate of 1,126.32%. Metagenomi's revenue in the past year totaled $55.08 million.
How much does Metagenomi make in a year?
Metagenomi's revenue by year for the past two years is:
Metagenomi's revenue for the twelve months ending Dec 31, 2023 was $44.76 million, a 160.21% increase year over year.
Metagenomi's annual revenue for Dec 31, 2022 was $17.20 million, a 6,978.19% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.